- JP-listed companies
- TEIJIN LIMITED
TEIJIN LIMITED (3401) Stock Price
Price and Volume
Market Cap
PER
PBR
Business Overview
Teijin operates primarily through three business segments. First, the "Materials" segment manufactures and sells high-performance materials and composite molded materials. Specifically, the company handles aramid fibers, resins, and carbon fibers through subsidiaries including Teijin Aramid B.V. and Teijin Polycarbonate China Ltd.
Second, the "Fibers & Products" segment manufactures and sells fiber products, polyester fibers, and textiles. This segment includes Teijin Frontier Co., Ltd. and Nantong Teijin Co., Ltd., which provide a wide range of fiber-related products.
The "Healthcare" segment manufactures and sells pharmaceuticals and medical devices, and provides home healthcare services. Teijin Pharma Co., Ltd. and Teijin Healthcare Co., Ltd. operate in this field, focusing on the development and provision of healthcare-related products.
In addition, the company manufactures and sells battery materials and membranes, and develops, manufactures, and sells regenerative medicine products and implantable medical devices. Teijin Lielsort Korea Co., Ltd. and Japan Tissue Engineering Co., Ltd. are involved in these operations.
Management Policy
Teijin established its purpose in April 2024: "Pioneering solutions together for a healthy planet." This purpose aims to provide solutions that protect the global environment and human health. Teijin takes pride in inheriting its pioneering spirit built over 100 years of history and contributing to solving social challenges through innovation.
Teijin's medium-term management plan "2024-2025" focuses on three priority areas: improving profitability, transforming the business portfolio, and strengthening the global management foundation. To improve profitability, the company will recover baseline earnings power through increased labor productivity, price adjustments, and fixed cost reduction. Establishing stable supply systems and reducing costs in the aramid and healthcare businesses are particularly important.
In business portfolio transformation, Teijin will divest unprofitable operations and streamline non-core businesses while pursuing growth in three key industrial sectors: mobility, infrastructure & industrial, and healthcare. The company is specifically advancing a shift from providing individual materials and products to delivering customer-centric value solutions.
Strengthening the global management foundation involves optimizing governance structures, advancing production technology, and enhancing human capital. Specifically, the company aims to achieve faster decision-making and optimal resource allocation through transitioning to an audit committee structure and implementing a global job posting system.
In fiscal 2025, Teijin will formulate its next medium-term management plan and pursue growth strategies to expand baseline earnings power and solve customer challenges. Teijin targets sustained growth and long-term corporate value enhancement, aiming to achieve ROE of 10% or higher and PBR of 1.0x or higher.